Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the production of kinase inhibitors for cancer treatment. It serves as a building block in the development of active pharmaceutical ingredients (APIs) due to its reactive amino and nitrile functional groups, which allow for further chemical modifications. Also employed in the preparation of agrochemicals and specialty organic compounds where trifluoromethyl groups enhance metabolic stability and lipophilicity. Its structure supports the design of high-affinity ligands in medicinal chemistry research.